Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions
Launched by CAIRO UNIVERSITY · Oct 13, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for treating a specific type of gum recession called Miller Class III recession. The study compares a technique that uses a special type of graft (called albumin PRF) with a traditional method that uses connective tissue grafts. The goal is to see which method is more effective in helping patients regain healthy gums.
To participate in this trial, you need to be at least 18 years old and have good oral hygiene. Unfortunately, smokers and individuals with poor oral hygiene cannot join. If you are eligible and choose to take part, you will receive one of the two treatments and will be monitored to see how well it works. It's important to know that this trial is not yet recruiting participants, so there will be opportunities to join in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years old good oral hygiene
- Exclusion Criteria:
- • smokers patients with poor oral hygiene
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Enji EA Ahmed, BDS.MDS.PHD
Study Director
Cairo University
Sarah SE Elbanna, BDS.MDS.PHD
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported